# The Use of Liposomated Iron After Bariatric Surgery in Patients That Are Receiving Parentheral Therapy With Iron

> **NCT02390921** · PHASE4 · COMPLETED · sponsor: **Hospital Universitari Vall d'Hebron Research Institute** · enrollment: 40 (actual)

## Conditions studied

- Liposomated Iron
- Y-de-Roux Gastric By-Pass
- Parenteral Iron Therapy

## Interventions

- **DRUG:** Fisiogen Ferro Forte
- **DRUG:** Venofer

## Key facts

- **NCT ID:** NCT02390921
- **Lead sponsor:** Hospital Universitari Vall d'Hebron Research Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-02
- **Primary completion:** 2015-10
- **Final completion:** 2015-11
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2017-04-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02390921

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02390921, "The Use of Liposomated Iron After Bariatric Surgery in Patients That Are Receiving Parentheral Therapy With Iron". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02390921. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
